or Try an Advanced Search...

    Technical Analysis for CVM - Cel-Sci Corporation

    Grade Last Price % Change Price Change
    F 1.13 -2.59% -0.03
    CVM closed down 2.59 percent on Monday, July 1, 2024, on approximately normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CVM trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish -2.59%
    BB Squeeze Ended Range Expansion -2.59%
    Lower Bollinger Band Touch Weakness -2.59%
    Bollinger Band Squeeze Range Contraction -4.24%
    Gapped Up Strength -4.24%
    New Downtrend Bearish -2.59%
    Bollinger Band Squeeze Range Contraction -2.59%
    Bollinger Band Squeeze Range Contraction -8.13%
    Older End-of-Day Signals for CVM ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 10 hours ago
    Down 1% 3 days ago
    Up 1% 3 days ago
    Down 1% 4 days ago
    Up 2% 4 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CVM Chart by TradingView
    Basic chart:

    Profile

    Cel-Sci Corporation Description

    CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Immunology Immune System Immunotherapy Vaccines Autoimmunity Rheumatoid Arthritis Vaccination Transplantation Cytokine Head And Neck Cancer Antigen Immune Response Allergies

    Is CVM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 18 CEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target Population
    Jun 6 Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor
    May 16 Cel-Sci GAAP EPS of -$0.28 misses by $0.15
    May 16 CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results
    May 8 CEL-SCI gains as FDA greenlights confirmatory study for Multikine
    May 8 CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
    Apr 23 CEL-SCI Appoints Mario Gobbo to Its Board of Directors
    Mar 19 CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
    Mar 6 CEL-SCI Corporation Issues Letter to Shareholders
    Feb 15 Cel-Sci GAAP EPS of -$0.14
    See more CVM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.23
    52 Week Low 1.04
    Average Volume 338,374
    200-Day Moving Average 1.90
    50-Day Moving Average 1.34
    20-Day Moving Average 1.24
    10-Day Moving Average 1.20
    Average True Range 0.10
    RSI (14) 39.02
    ADX 24.8
    +DI 14.14
    -DI 20.10
    Chandelier Exit (Long, 3 ATRs) 1.08
    Chandelier Exit (Short, 3 ATRs) 1.38
    Upper Bollinger Bands 1.37
    Lower Bollinger Band 1.11
    Percent B (%b) 0.08
    BandWidth 21.23
    MACD Line -0.05
    MACD Signal Line -0.05
    MACD Histogram -0.0034
    Fundamentals Value
    Market Cap 56.48 Million
    Num Shares 50 Million
    EPS -0.73
    Price-to-Earnings (P/E) Ratio -1.55
    Price-to-Sales 11797.42
    Price-to-Book 9.30
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.28
    Resistance 3 (R3) 1.28 1.23 1.26
    Resistance 2 (R2) 1.23 1.19 1.23 1.25
    Resistance 1 (R1) 1.18 1.17 1.16 1.18 1.24
    Pivot Point 1.13 1.13 1.12 1.13 1.13
    Support 1 (S1) 1.08 1.09 1.05 1.08 1.02
    Support 2 (S2) 1.03 1.07 1.03 1.01
    Support 3 (S3) 0.98 1.03 1.00
    Support 4 (S4) 0.98